Published October 2021 | Version v1
Journal article

Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems

  • 1. Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061 (United States)
  • 2. Department of Entomology, College of Agriculture and Life Sciences, Fralin Life Science Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061 (United States)
  • 3. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555 (United States)

Description

Highlights: • Aripo virus is a novel dual host insect-specific flavivirus isolated from Trinidad. • Aripo virus antigen shows strong cross-reactivity with Japanese encephalitis virus serogroup antisera. • Aripo virus infection generates a robust innate immune response despite an inability to replicate in vertebrate systems. • Prior infection or coinfection with Aripo virus limits West Nile virus-induced disease in mouse models. We describe the isolation and characterization of a novel insect-specific flavivirus (ISFV), tentatively named Aripo virus (ARPV), that was isolated from Psorophora albipes mosquitoes collected in Trinidad. The ARPV genome was determined and phylogenetic analyses showed that it is a dual host associated ISFV, and clusters with the main mosquito-borne flaviviruses. ARPV antigen was significantly cross-reactive with Japanese encephalitis virus serogroup antisera, with significant cross-reactivity to Ilheus and West Nile virus (WNV). Results suggest that ARPV replication is limited to mosquitoes, as it did not replicate in the sandfly, culicoides or vertebrate cell lines tested. We also demonstrated that ARPV is endocytosed into vertebrate cells and is highly immunomodulatory, producing a robust innate immune response despite its inability to replicate in vertebrate systems. We show that prior infection or coinfection with ARPV limits WNV-induced disease in mouse models, likely the result of a robust ARPV-induced type I interferon response.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.virol.2021.07.004

Additional details

Identifiers

DOI
10.1016/j.virol.2021.07.004;
PII
S0042682221001513;

Publishing Information

Journal Title
Virology (New York, N.Y. Print)
Journal Volume
562
Journal Page Range
p. 50-62
ISSN
0042-6822
CODEN
VIRLAX

Optional Information

Notes
Published by Elsevier Inc.